Loading...
Cognition Therapeutics, Inc.
CGTX•NASDAQ
Healthcare
Biotechnology
$0.61
$0.08(14.58%)
Cognition Therapeutics, Inc. (CGTX) Financial Performance & Statements
Review Cognition Therapeutics, Inc.’s income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Revenue Growth
0.00%
Operating Income Growth
-6.39%
↓ 6.39%
Net Income Growth
-31.73%
↓ 31.73%
Operating Cash Flow Growth
-77.76%
↓ 77.76%
Operating Margin
0.00%
Gross Margin
0.00%
Net Profit Margin
0.00%
ROE
-194.42%
↓ 194.42%
ROIC
-427.40%
↓ 427.40%
Cognition Therapeutics, Inc. (CGTX) Financial Statements
Explore quarterly and annual reports for Cognition Therapeutics, Inc. stock.
| Metric | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 |
|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $372000.00 |
| Cost of Revenue | $0.00 | $67000.00 | $58000.00 | $66000.00 |
| Gross Profit | $0.00 | -$67000.00 | -$58000.00 | $306000.00 |
| Gross Profit Ratio | $0.00 | $0.00 | $0.00 | $0.82 |
| R&D Expenses | $11.39M | $11.58M | $10.55M | $11.60M |
| SG&A Expenses | $3.07M | $3.10M | $3.49M | $3.52M |
| Operating Expenses | $14.46M | $14.68M | $14.04M | $15.12M |
| Total Costs & Expenses | $14.46M | $14.68M | $14.10M | $15.19M |
| Interest Income | $0.00 | $0.00 | $0.00 | $6.77M |
| Interest Expense | $3000.00 | $7000.00 | $10000.00 | $9000.00 |
| Depreciation & Amortization | $70000.00 | $67000.00 | $58000.00 | $66000.00 |
| EBITDA | -$9.86M | -$6.97M | -$9.08M | -$8.07M |
| EBITDA Ratio | $0.00 | $0.00 | $0.00 | -$40.65 |
| Operating Income | -$14.46M | -$14.68M | -$14.10M | -$15.19M |
| Operating Income Ratio | $0.00 | $0.00 | $0.00 | -$40.83 |
| Other Income/Expenses (Net) | $4.53M | $7.64M | $4.95M | $7.05M |
| Income Before Tax | -$9.94M | -$7.04M | -$9.15M | -$8.14M |
| Income Before Tax Ratio | $0.00 | $0.00 | $0.00 | -$21.88 |
| Income Tax Expense | $0.00 | $0.00 | $14724.00 | $2.30M |
| Net Income | -$9.94M | -$7.04M | -$9.15M | -$8.14M |
| Net Income Ratio | $0.00 | $0.00 | $0.00 | -$21.88 |
| EPS | -$0.25 | -$0.18 | -$0.27 | -$0.26 |
| Diluted EPS | -$0.25 | -$0.18 | -$0.27 | -$0.26 |
| Weighted Avg Shares Outstanding | $40.42M | $40.06M | $33.74M | $30.78M |
| Weighted Avg Shares Outstanding (Diluted) | $40.42M | $40.06M | $33.74M | $30.78M |
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan